ASCEND, Accelerating Solutions for Commercialization and Entrepreneurial Development in the Mountain West IDeA States
ASCEND, Accelerating Solutions for Commercialization and Entrepreneurial Development in the Mountain West IDeA States
批准号:
9621296
负责人:
Neil A Fanger
金额:
$50.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2019-08-31
关键词:
AddressAdvisory CommitteesAffectAlaskaAwardAwarenessBasic ScienceBusinessesCapitalCommunicationConsultDevelopmentEcosystemEducationEducational CurriculumEducational MaterialsEducational workshopEnsureEntrepreneurshipEvaluationExposure toFacultyFeasibility StudiesFundingFutureGoalsHawaiiHealthHealthcareHumanIdahoIndustryInstitutesInstitutionIntellectual PropertyKnowledgeLeadershipLearningLegal patentLicensingMeasuresMentorsModelingMontanaNevadaNew MexicoPerformancePersonsPhasePilot ProjectsPostdoctoral FellowRegulatory PathwayResearchResearch InfrastructureResearch PersonnelResource SharingResourcesScientistServicesSiteSmall Business Innovation Research GrantSmall Business Technology Transfer ResearchStructureStudentsTechnologyTechnology TransferTestingTextTrainingTraining and EducationTraining and InfrastructureTranslational ResearchUnited States National Institutes of HealthUniversitiesVisitWorkWyomingcommercializationcourse moduledesigngraduate studentindustry partnerinnovationinventionmeetingsmembernext generationoutreachprogramsprototypeskillsstudent trainingtechnology developmentundergraduate studentvalidation studieswebinar
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The objective of this proposal is to create a Mountain West region technology Accelerator Hub to conduct
research on developing, implementing, and testing a comprehensive collateral and consulting offering for
promoting biomedical entrepreneurship, technology transfer, management, small business finance, and
additional business skills needed to commercialize basic research to enhance human health.
Many limiting factors hamper the ultimate goal of commercializing basic and translational science in IDeA
states, including a gap in funding between basic research discoveries and scientific feasibility or validation
studies required to define a product for early stage technology development, a lack of knowledge and
understanding by innovators about how technologies are brought to market, a lack of access to sufficient
technology development and commercialization resources for early-stage technology development, limited
resources in Technology Transfer and Commercialization Offices, an insufficient number of local technology
businesses to create a critical mass of entrepreneurial expertise and culture; a lack of exposure to
commercialization education, training, and mentoring (including in patents, startups, business plans, venture
capital and angel investing), a limited knowledge of technology transfer and SBIR/STTR programs; and a lack
of awareness of available resources at the local, state and regional levels.
To address these goals, we propose to create a regional technology Accelerator Hub throughout the Mountain
West (Western) region of IDeA states that is closely networked with Mountain West IDeA state universities and
their affiliated Technology Transfer Offices and small business partners. This network will provide the
framework for effective communication and outreach that will create institutional change and build an
entrepreneurial culture throughout this region. We will provide robust education and training of students and
researchers and other entrepreneurs to accelerate development of commercialization activities, substantially
increasing SBIR/STTR applications and facilitating communication between the NIH and IDeA institutions.
The objectives of this application are to: 1) establish infrastructure, develop educational materials (curricula,
texts, webinars, workshops and courses), and train staff; 2) accelerate entrepreneurialism through innovator
mentoring, SBIR/STTR application submission, and increased partnering activity; 3) increase visibility of
technological advancements, industry partnerships and licensing revenues through outreach, coaching and
partnering activities, at each of the Mountain West IDeA state institutions.
The product of this work will be the ASCEND solution, a comprehensive, sustainable educational and
consulting services offering that will be leveraged across the Mountain West IDeA States-collaborating
biomedical institutions and marketed to other institutions that want to accelerate biomedical entrepreneurship,
thus ensuring the long-term sustainability, dissemination, and impact of this program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Sublingual Vaccine to Prevent Neisseria Gonorrhoeae Infection
-
批准号:10699065
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2023
-
负责人:Neil A Fanger
-
依托单位:
A Novel Antibody that Promotes Neuronal Integrity and Neurogenesis for Treating Alzheimer's Disease
-
批准号:10721794
-
项目类别:
-
资助金额:$21.57万
-
财政年份:2022
-
负责人:Neil A Fanger
-
依托单位:
A Novel Bispecific Antibody for the Treatment of Idiopathic Pulmonary Fibrosis
-
批准号:10594937
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2022
-
负责人:Neil A Fanger
-
依托单位:
A Novel Antibody that Promotes Neuronal Integrity and Neurogenesis for Treating Alzheimer's Disease
-
批准号:10600796
-
项目类别:
-
资助金额:$44.13万
-
财政年份:2022
-
负责人:Neil A Fanger
-
依托单位:
A Novel Small Molecule for the Treatment of Periodontitis
-
批准号:10481054
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2022
-
负责人:Neil A Fanger
-
依托单位:
A Novel Bispecific Antibody for the Treatment of Idiopathic Pulmonary Fibrosis
-
批准号:10482438
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2022
-
负责人:Neil A Fanger
-
依托单位:
A Novel Antibody that Promotes Neuronal Integrity and Neurogenesis for Treating Alzheimer's Disease
-
批准号:10706541
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2022
-
负责人:Neil A Fanger
-
依托单位:
A Novel Antibody that Promotes Neuronal Integrity and Neurogenesis for Treating Alzheimer's Disease
-
批准号:10893118
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2022
-
负责人:Neil A Fanger
-
依托单位:
A Novel Multiparameter Blood Test for Early Detection of Alzheimer's Disease
-
批准号:10570790
-
项目类别:
-
资助金额:$3.05万
-
财政年份:2021
-
负责人:Neil A Fanger
-
依托单位:
A Novel Multiparameter Blood Test for Early Detection of Alzheimer's Disease
-
批准号:10491891
-
项目类别:
-
资助金额:$29.2万
-
财政年份:2021
-
负责人:Neil A Fanger
-
依托单位:
A Novel Multiparameter Blood Test for Early Detection of Alzheimer's Disease
-
批准号:10683848
-
项目类别:
-
资助金额:$7.32万
-
财政年份:2021
-
负责人:Neil A Fanger
-
依托单位:
A Novel Multiparameter Blood Test for Early Detection of Alzheimer's Disease
-
批准号:10384224
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2021
-
负责人:Neil A Fanger
-
依托单位:
A Novel IL-35 Expressing Probiotic Platform for Inducing Allergen Specific Tolerance
-
批准号:10395654
-
项目类别:
-
资助金额:$99.42万
-
财政年份:2020
-
负责人:Neil A Fanger
-
依托单位:
A Novel IL-35 Expressing Probiotic Platform for Inducing Allergen Specific Tolerance
-
批准号:10450744
-
项目类别:
-
资助金额:$97.95万
-
财政年份:2020
-
负责人:Neil A Fanger
-
依托单位:
A Novel IL-35 Expressing Probiotic Platform for Inducing Allergen Specific Tolerance
-
批准号:10662445
-
项目类别:
-
资助金额:$97.88万
-
财政年份:2020
-
负责人:Neil A Fanger
-
依托单位:
A Novel Probiotic-Based Nanobody Delivery Platform
-
批准号:9909112
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2020
-
负责人:Neil A Fanger
-
依托单位:
A Novel Probiotic-Based Nanobody Delivery Platform
-
批准号:10089220
-
项目类别:
-
资助金额:$28.11万
-
财政年份:2020
-
负责人:Neil A Fanger
-
依托单位:
A Novel Therapeutic Peptide to Treat P. aeruginosa Infection in Cystic Fibrosis Patients
-
批准号:9975726
-
项目类别:
-
资助金额:$15.88万
-
财政年份:2019
-
负责人:Neil A Fanger
-
依托单位:
ASCEND, Accelerating Solutions for Commercialization and Entrepreneurial Development in the Mountain West IDeA States
-
批准号:10002255
-
项目类别:
-
资助金额:$137.47万
-
财政年份:2018
-
负责人:Neil A Fanger
-
依托单位:
ASCEND, Accelerating Solutions for Commercialization and Entrepreneurial Development in the Mountain West IDeA States
-
批准号:9983365
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2018
-
负责人:Neil A Fanger
-
依托单位:
海外基金